Ignite Creation Date:
2024-05-06 @ 10:26 AM
Last Modification Date:
2024-10-26 @ 12:30 PM
Study NCT ID:
NCT03256136
Status:
COMPLETED
Last Update Posted:
2020-11-04
First Post:
2017-08-17
Brief Title:
Nivolumab in Combination With Chemotherapy or Nivolumab in Combination With Ipilimumab in Advanced EGFR-Mutant or ALK-Rearranged NSCLC
Sponsor:
Organization:
Massachusetts General Hospital